Back
Roundhill GLP-1 & Weight Loss ETF Vs. Amplify Weight Loss Drug & Treatment ETF Industry Stock Comparison
Sell
38
OZEM
Roundhill GLP-1 & Weight Loss ETF
Last Price:
25.85
Seasonality Move:
--
Sell
12
THNR
Amplify Weight Loss Drug & Treatment ETF
Last Price:
23.15
Seasonality Move:
--
Sell
38
Roundhill GLP-1 & Weight Loss ETF (OZEM)
is a Sell
Is Roundhill GLP-1 & Weight Loss ETF a Buy, Sell or Hold?
- The current Roundhill GLP-1 & Weight Loss ETF [OZEM] share price is $25.91. The Score for OZEM is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- OZEM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
12
Amplify Weight Loss Drug & Treatment ETF (THNR)
is a Sell
Is Amplify Weight Loss Drug & Treatment ETF a Buy, Sell or Hold?
- The current Amplify Weight Loss Drug & Treatment ETF [THNR] share price is $23.36. The Score for THNR is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
- THNR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
OZEM Stock Price Chart
What is Roundhill GLP-1 & Weight Loss ETF's stock price today?
-
The Roundhill GLP-1 & Weight Loss ETF share price today is $25.91
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OZEM is experiencing buying pressure, which is a positive indicator for future bullish movement.
THNR Stock Price Chart
What is Amplify Weight Loss Drug & Treatment ETF's stock price today?
-
The Amplify Weight Loss Drug & Treatment ETF share price today is $23.36
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and THNR is experiencing slight selling pressure.
OZEM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.69 | Sell |
| Relative Strength Index (14 RSI): | 40.66 | Sell |
| Chaikin Money Flow: | 15857 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.93 - 28.17) | Sell |
| Bollinger Bands (100): | (26.68 - 28.6) | Sell |
THNR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.81 | Sell |
| Relative Strength Index (14 RSI): | 28.75 | Sell |
| Chaikin Money Flow: | -483 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.66 - 25.9) | Sell |
| Bollinger Bands (100): | (25.1 - 27.48) | Sell |
OZEM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.67 | Buy |
| 20-day SMA: | 26.75 | Sell |
| 50-day SMA: | 27.64 | Sell |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 25.8 | Buy |
| 20-day EMA: | 26.53 | Sell |
| 50-day EMA: | 27.22 | Sell |
| 200-day EMA: | 10.31 | Buy |
THNR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.35 | Buy |
| 20-day SMA: | 24.46 | Sell |
| 50-day SMA: | 25.8 | Sell |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 23.47 | Sell |
| 20-day EMA: | 24.27 | Sell |
| 50-day EMA: | 25.32 | Sell |
| 200-day EMA: | 8.52 | Buy |
Roundhill GLP-1 & Weight Loss ETF Earnings Growth & OZEM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Amplify Weight Loss Drug & Treatment ETF Earnings Growth & THNR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Roundhill GLP-1 & Weight Loss ETF Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amplify Weight Loss Drug & Treatment ETF Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||